Internet-administered CBT for Young Adults With Low Self-esteem

Sponsor
Linkoeping University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05180084
Collaborator
(none)
100
2
16.1

Study Details

Study Description

Brief Summary

The study will investigate a CBT based treatment approach for low self-esteem among young adults.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive behavior therapy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Internet-administered Cognitive Behavioural Therapy for Young Adults With Low Self-esteem
Anticipated Study Start Date :
Feb 7, 2022
Anticipated Primary Completion Date :
Jun 13, 2022
Anticipated Study Completion Date :
Jun 13, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cognitive Behavior Therapy

Therapist-Guided Internet based Cognitive Behavior Therapy

Behavioral: Cognitive behavior therapy
Internet-based CBT intervention based on CBT theory, self-determination theory and self-compassion therapy for low self-esteem among young adults.

No Intervention: Wait-list control

Wait-list control participants will receive the same treatment at the end of the study period.

Outcome Measures

Primary Outcome Measures

  1. Change in Rosenberg Self-Esteem Scale [Before treatment, after 3 weeks, after 7 weeks and follow-up at 12 months after treatment termination]

    A 10-item measure of self-esteem. Sum scores range between 0-30. A higher score indicates a higher self-esteem.

Secondary Outcome Measures

  1. Change in Brunnsviken Brief Quality of Life Questionnaire [Before treatment, after 7 weeks and follow-up at 12 months after treatment termination.]

    Measure of subjective quality of life. Sum scores can range between 0 and 96. Higher scores indicate a higher quality of life.

  2. Change in Robson Self-concept Questionnaire [Before treatment, after 7 weeks and follow-up at 12 months after treatment termination.]

    A 30-item measure of self-esteem. Sum scores range between 0-210. A higher score indicates a higher self-esteem.

  3. Change in Self-Compassion Scale Short Format [Before treatment, after 7 weeks and follow-up at 12 months after treatment termination.]

    A 12-item measure of self-compassion. Sum scores range between 1-5. A higher score indicates higher self-compassion.

  4. Change in Patient Health Questionnaire [Before treatment, after 7 weeks and follow-up at 12 months after treatment termination.]

    A 9 item measure of depressive symptoms. Sum scores range from 0-27. A higher score indicates more depressive symptoms.

  5. Change in Generalised Anxiety Disorder 7-item scale [Before treatment, after 7 weeks and follow-up at 12 months after treatment termination]

    Seven item measure of generalized anxiety disorder. Sum score range from 0 to 21, with higher scores indicating more generalized anxiety. Cut-offs for interpretation: 0-5 minimal anxiety, 6-9 mild anxiety, 10-14 moderate anxiety, and 15-21 severe anxiety.

  6. Change in Alcohol Use Disorder Identification Test [Before treatment, after 7 weeks and follow-up at 12 months after treatment termination.]

    A 10 item measure of alcohol use disorders. Sum scores range from 0-40. A higher score indicates higher alcohol use.

  7. Change in Performance based self-esteem Scale [Before treatment, after 7 weeks and follow-up at 12 months after treatment termination]

    A 4-item measure of performance based self-esteem. Sum scores range between 4-20. A higher score indicates a higher performance based self-esteem.

  8. Change in Rathus assertiveness schedule - 6 [Before treatment, after 7 weeks and follow-up at 12 months after treatment termination]

    Six item measure of assertiveness. Sum score range from -18 to 18. A higher score indicates higher assertiveness.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 25 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Low self-esteem, as indicated by rating of < 20 the Rosenberg Self-Esteem Scale.

Age between 18 and 25 years old. Access to a computer, smartphone, or tablet with internet access. Write and speak Swedish. In case of use of psychotropical medication, a stable dose for the past three months prior to registration and no planned changes during the treatment.

Exclusion Criteria:

Other ongoing psychological treatment that affects the treatment received in the study.

No comorbid severe depressive symptoms and no suicidal plans. Ongoing alcohol use disorder, as indicated by Alcohol Use Disorders Identification Test (AUDIT).

Severe psychiatric comorbidities (e.g. psychosis, anorexia nervosa) that requires specialist care within the regular psychiatric care.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Linkoeping University

Investigators

  • Principal Investigator: Gerhard Andersson, Linkoeping University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gerhard Andersson, Professor, Linkoeping University
ClinicalTrials.gov Identifier:
NCT05180084
Other Study ID Numbers:
  • SIYA
First Posted:
Jan 6, 2022
Last Update Posted:
Jan 6, 2022
Last Verified:
Dec 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 6, 2022